Skip to content

FITLIFE BRANDS, INC.

FTLF · XNAS

CIK 1374328fmd_0NM616MWKYF895HA6J7YW7MAZVManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues25181719222829536416
Cost of revenue1513101113151731369
Net interest income––––(0)00–––
Gross profit1057810131221287
Realized investment gains (losses)0–––––––––
Selling, general and administrative98655668103
Total operating expenses10146556614154
Operating income0(9)124668133
Interest expense00000–0110
Interest and investment income–––00–0000
Other non-operating income (expense)(0)(0)(0)0000(1)(1)(0)
Income before taxes0(9)134767123
Income tax expense0100(4)11231
Net income from continuing operations(0)(10)13954592
Net income0113954592
Net income to common shareholders–(10)039–––––
FITLIFE BRANDS, INC. (FTLF) financial statements · FinancialMD